Steps taken to strengthen security of cyber ecosystem (See 'Corp Brief') IPR - While assessing 'prior art', mere similarity is insufficient and visual distinction matters, and for prior art to invalidate design, it must be clearly established and comparable in relevant features: HC (See 'Legal Desk') ICG Ship Sarthak makes Strategic Port Call at Chabahar (See 'Corp Brief') IPR - On being satisfied that brand or mark has acquired status which is well known, there ought to be order directing that no individuals should be allowed to register UPI Ids or VPAs with said brand names: HC (See 'Legal Desk') CCI okays acquisition of paper & pulp manufacturing business of ABREL by ITC Ltd (See 'Corp Brief') CCI okays acquisition of equity stake in Logisteed Holdings, Ltd. by Japan Post Co., Ltd. (See 'Corp Brief') CCI nod to proposed combination involving acquisition of minority shareholding in DCX Global Limited by Coinbase Global Inc. (See 'Corp Brief') IBC - Compromise between bank and co-guarantor did not extinguish liability of other guarantors, who issued separate, enforceable undertakings: HC (See 'Legal Desk') Motor insurance complaints fall from 26.18% in FY 2023-24 to 24.8% in FY 2024-25 (See 'Corp Brief') DPIIT launches District Business Reform Action Plan (See 'Corp Brief') MoHUA holds Preparatory Workshop to Chart Roadmap for Clean Himalayan Hill Cities (See 'Corp Brief') IPR - Visage had made out strong prima facie case for protection; Freecia is restrained from copying packaging layout, ingredient descriptions, usage steps or using mark 'DERMOMELAN' until final disposal of suit: HC (See 'Legal Desk') BHEL hands over dividend cheque of Rs 109 cr to GoI (See 'Corp Brief') NESTS is organising 2nd EMRS Principals' Conclave on Effective Management of Schools (See 'Corp Brief') Govt has focused on further decriminalization to enhance Ease of Living and EODB: MoS (See 'Corp Brief') A&C - Post-insolvency commencement date claims that are not made part of Resolution Plan are not arbitrable: HC (See 'Legal Desk') Relentless execution transformed India's Energy Sector: Goyal (See 'Corp Brief') Over 8.45 crore subscribers enrolled under APY as on 30th Nov: MoS (See 'Corp Brief') Misc - It is duty of litigant to keep track of his own case, and he cannot shift entire burden on to shoulders of his counsel: HC (See 'Legal Desk') Rail Electrification boosts Efficiency, Cuts Diesel Consumption and Sets Global Benchmark (See 'Corp Brief') 53rd Edition of Fit India Sundays on Cycle dedicated to Vijay Diwas held in Goa (See 'Corp Brief') Scindia unveils 25-Foot Statue of Chhatrapati Shivaji Maharaj in Karnataka (See 'Corp Brief') PMLA - Secured creditor is entitled to stake its claim before liquidator as per Section 53 of IBC, qua immovable property, and same can be disposed of by liquidator as per law: SAFEMA (See 'Legal Desk') Mizoram gets its First Rail-Carried Cars (See 'Corp Brief') Minister highlighting rich craft traditions and their relevance to contemporary living (See 'Corp Brief') Scindia unveils Commemorative Postage Stamp on 150th anniversary of Bombay Gymkhana (See 'Corp Brief') SEBI - Request for unfreezing bank accounts based merely on value of securities in demat accounts, in absence of compliance with direction of Interim Order of depositing impounded gains in Escrow Account, cannot be accepted: SEBI (See 'Legal Desk')

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.